MINNEAPOLIS--(BUSINESS WIRE)--Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or, the "Company"), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, industrial and defense markets, reported 2023 fourth quarter and full year results for the period ended December 31, 2023.
2023 Highlights:
- Net sales of $139.3 million, up 3.9% from the prior year.
- Net income of $6.9 million, or $2.38 per diluted share, compared with net income of $2.0 million, or $0.70 per diluted share, in 2022. Fourth quarter 2023 net income includes a non-cash tax benefit of $2.6 million for the reversal of a previously established tax valuation allowance.
- Gross margin of 16.6%, up 130 basis points from gross margin of 15.3% in the prior year.
- Earnings before interest, taxes, depreciation, and amortization (EBITDA) of $8.0 million, compared with EBITDA of $5.8 million in the prior year.
- Year-end 90-day backlog of $35.1 million as of December 31, 2023, consistent with the prior year-end level.
Management Commentary
“As expected, we ended 2023 strong, including record revenue both in the fourth quarter and the year, continued expense management and solid margins,” said Jay D. Miller, President and CEO of Nortech. “We saw encouraging normalization trends in supply chain and customer ordering practices, approaching pre-Covid levels. These factors had inflated our backlog levels in 2022 and early 2023, but we believe the situation has returned to a steady state.
“Our overall financial results are a credit to the nearly 800 dedicated Nortech employees worldwide who embody our corporate values, including teamwork, excellence, commitment, integrity and innovation,” Miller noted. “I am proud of Nortech’s collaborative culture and the important role it plays in successfully retaining our people; they truly are our most valuable asset in delivering mission-critical products and solutions to our customers.
“For example, our highly skilled engineering services team is essential to providing our customers with Nortech’s full-system solution by helping them to improve manufacturability of products and reduce costs,” explained Miller. “Nortech’s ability to quickly and flexibly adapt our global resources to fit our customers’ changing needs is a key competitive advantage.”
2023 Fourth Quarter and Full Year Results
($ in thousands) |
Q4 23 |
Q4 22 |
% |
Full Year 2023 |
Full Year 2022 |
% |
Net sales |
$36,054 |
$35,618 |
1.2 % |
$139,332 |
$134,123 |
3.9% |
Gross Profit |
$6,827 |
$5,104 |
33.8 % |
$23,104 |
$20,480 |
12.8% |
Operating Expenses |
$4,151 |
$4,255 |
2.4% |
$17,151 |
$16,592 |
(3.4%) |
Net Income |
$4,352 |
$(381) |
N/A |
$6,874 |
$2,010 |
242.0% |
EBITDA |
$3,188 |
$1,227 |
159.8% |
$8,003 |
$5,791 |
38.2% |
In 2023, net sales totaled $139.3 million. This represents a 3.9% increase from net sales of $134.1 million in 2022. GAAP net income totaled $6.9 million, or $2.38 per diluted share, in 2023, up from GAAP net income of $2.0 million, or $0.70 per diluted share, in the prior year. Fourth quarter 2023 GAAP net income included a non-cash tax benefit of $2.6 million related to the release of a previously established tax valuation allowance in alignment with the Company’s historical and projections of future taxable income.
For the full year 2023, gross profit totaled $23.1 million, or 16.6%, compared with gross profit of $20.5 million, or 15.3%, in the prior year.
In 2023 operating expenses totaled $17.2 million, a 3.4% increase from the prior year operating expenses of $16.6 million. The increase in year-over-year operating expense was primarily driven by investments in information technology and human resource systems earlier in the year, payroll and inflationary pressures.
In 2023 EBITDA totaled $8.0 million, a 38.2% increase from EBITDA of $5.8 million in the prior year. The year-over-year increase in EBITDA resulted primarily from the previously highlighted net sales increase over the same period.
Business Outlook
“We expect our positive momentum to continue into 2024, buoyed by encouraging industry trends and our own solid internal execution,” commented Miller. “Last month the global trade organization IPC released survey results forecasting industry revenue growth in 2024. This outlook, plus continued normalization of customer demand levels, supply chain improvements, and our careful expense management, gives us confidence as we go forward.
“Nortech remains focused on business fundamentals including generating cash and strengthening our balance sheet. In support of that, we recently restructured our credit agreement with Bank of America to increase our borrowing capacity and better complement our business.
“We are prudently investing in promising new technologies that will benefit both our customers and the environment,” explained Miller. Earlier this year, Nortech introduced Expanded Beam Xtreme™ fiber optic technology, designed for digital data transmission and offering boosted speed, reliability and interference protection. Concluded Miller, “Along with enhanced performance capabilities, fiber optics offer our customers many sustainability advantages over traditional copper wire, in both production and operation. Benefits include greater durability, improved energy efficiency and less material usage.”
Conference Call
The Company will hold a live conference call and webcast at 4:00 p.m. central time on Wednesday, March 20, 2024, to discuss the Company's 2023 fourth quarter and full year results. The call will be hosted by Jay Miller, Chief Executive Officer and President and Andrew LaFrence, Chief Financial Officer. To access the live audio conference call, U.S. participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 823360. Participants may also access the call via webcast at: https://www.webcaster4.com/Webcast/Page/2814/50217.
About Nortech Systems Incorporated
Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire/cable/interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has seven manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech's website is www.nortechsys.com.
Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding future financial results, improving supply chain management, the impact of new products and innovations on our customers' and our results, sales booking and backlog trends, customer demand, continued high performance of personnel, and industry revenue trends. While this release is based on management's best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company's products; (4) increased competition; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions; (9) the Company's ability to steadily improve manufacturing output and product quality throughout the remainder of 2024 or (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition. Some of the above-mentioned factors are described in further detail in the section entitled "Risk Factors" in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.
Reconciliation of Generally Accepted Accounting Principles (“GAAP”) Measures to Non-GAAP Financial Measure
EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. It is not a measurement of our financial performance under GAAP and should not be considered an alternative to revenue or net income, as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA has limitations as an analytical metric and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.
| THREE MONTHS ENDED | TWELVE MONTHS ENDED | |||||||||||
| December 31, | December 31, | |||||||||||
| INCOME STATEMENTS | 2023 |
2022 |
2023 |
2022 |
||||||||
| (in thousands USD, except share and per share amounts) | ||||||||||||
| Net Sales | $ | 36,054 |
$ | 35,618 |
$ | 139,332 |
$ | 134,123 |
||||
| Cost of Goods Sold | 29,227 |
30,514 |
116,228 |
113,643 |
||||||||
| Gross Profit | 6,827 |
5,104 |
23,104 |
20,480 |
||||||||
18.9% |
14.3% |
16.6% |
15.3% |
|||||||||
| Operating Expenses | ||||||||||||
| Selling Expenses | 832 |
967 |
3,598 |
3,719 |
||||||||
| General and Administrative Expenses | 3,026 |
3,079 |
12,354 |
11,425 |
||||||||
| Research and Development Expenses | 292 |
309 |
1,199 |
1,463 |
||||||||
| Gain on Sale of Assets | - |
- |
- |
(15) |
||||||||
| Total Operating Expenses | 4,150 |
4,355 |
17,151 |
16,592 |
||||||||
| Income from Operations | 2,677 |
749 |
5,953 |
3,888 |
||||||||
| Other Expense | ||||||||||||
| Interest Expense | (122) |
(74) |
(487) |
(411) |
||||||||
| Income Before Income Taxes | 2,555 |
675 |
5,466 |
3,477 |
||||||||
| Income Tax (Benefit) Expense | (1,797) |
1,056 |
(1,408) |
1,467 |
||||||||
| Net Income (Loss) | $ | 4,352 |
$ | (381) |
$ | 6,874 |
$ | 2,010 |
||||
| Net Income (Loss) Per Common Share - Basic | $ | 1.59 |
$ | (0.14) |
$ | 2.53 |
$ | 0.75 |
||||
| Weighted Average Number of Common Shares Outstanding - Basic | 2,739,848 |
2,685,378 |
2,722,135 |
2,685,378 |
||||||||
| Net Income (Loss) Per Common Share - Diluted | $ | 1.51 |
$ | (0.14) |
$ | 2.38 |
$ | 0.70 |
||||
| Weighted Average Number of Common Shares Outstanding - Diluted | 2,879,654 |
2,685,378 |
2,885,879 |
2,891,285 |
||||||||
| CONDENSED BALANCE SHEETS | December 31, 2023 |
December 31, 2022 |
||||
| ($ in thousands ) | ||||||
| Cash | $ | 960 |
$ | 1,027 |
||
| Restricted Cash | 715 |
1,454 |
||||
| Accounts Receivable | 19,279 |
15,975 |
||||
| Employee Retention Credit Receivable | - |
2,650 |
||||
| Inventories, Net | 21,660 |
22,438 |
||||
| Contract Assets | 14,481 |
9,982 |
||||
| Prepaid Expenses and Other Current Assets | 1,698 |
1,334 |
||||
| Property and Equipment, Net | 6,513 |
6,408 |
||||
| Operating Lease Assets | 6,917 |
7,850 |
||||
| Other Intangible Assets, Net | 2,904 |
422 |
||||
| Total Assets | $ | 75,127 |
$ | 69,540 |
||
| Accounts Payable | $ | 15,924 |
$ | 14,792 |
||
| Lease Obligations, Finance & Operating, Net | 8,361 |
9,659 |
||||
| Accrued Payroll and Commissions | 4,138 |
4,803 |
||||
| Customer Deposits | 4,068 |
3,515 |
||||
| All Other Liabilities | 1,476 |
1,838 |
||||
| Line of Credit | 5,815 |
6,853 |
||||
| Shareholders’ Equity | 35,344 |
28,080 |
||||
Total Liabilities and Shareholders’ Equity |
$ | 75,127 |
$ | 69,540 |
| CASH FLOW STATEMENTS |
December 31,
|
December 31, 2022 |
||||||
| Cash Flows from Operating Activities | ||||||||
| ($ in thousands ) | ||||||||
| Net Income | $ | 6,874 |
|
$ | 2,010 |
|
||
| Depreciation and Amortization | 2,050 |
|
1,918 |
|
||||
| Compensation on Stock-Based Awards | 423 |
|
334 |
|
||||
| Deferred Taxes | (2,363 |
) |
- |
|
||||
| Change in Inventory Reserves | 26 |
|
(149 |
) |
||||
| Other, Net | 26 |
|
(81 |
) |
||||
| Changes in Current Operating Items | ||||||||
| Accounts Receivable | (3,432 |
) |
(1,746 |
) |
||||
| Inventories | 716 |
|
(2,985 |
) |
||||
| Contract Assets | (4,514 |
) |
(1,283 |
) |
||||
| Prepaid Expenses and Other Assets | (147 |
) |
317 |
|
||||
| Income Taxes | (832 |
) |
643 |
|
||||
| Accounts Payable | 483 |
|
2,216 |
|
||||
| Accrued Payroll and Commissions | (661 |
) |
783 |
|
||||
| Customer Deposits | 553 |
|
550 |
|
||||
| All Other Operating Items | 2,567 |
|
2,876 |
|
||||
| Net Cash Provided By Operating Activities | $ | 1,769 |
|
$ | 5,402 |
|
||
| Cash Flows from Investing Activities | ||||||||
| Proceeds from Sale of Property and Equipment | - |
|
15 |
|
||||
| Purchase of Property and Equipment | (1,284 |
) |
(2,442 |
) |
||||
| Net Cash Used In Investing Activities | $ | (1,284 |
) |
$ | (2,426 |
) |
||
| Cash Flows from Financing Activities | ||||||||
| Proceeds from Line of Credit | 124,552 |
|
119,349 |
|
||||
| Payments to Line of Credit | (125,602 |
) |
(121,468 |
) |
||||
| Principal Payments on Financing Leases | (390 |
) |
(599 |
) |
||||
| Stock Option Exercises | 159 |
|
51 |
|
||||
| Net Cash Used In Financing Activities | $ | (1,281 |
) |
$ | (2,667 |
) |
||
| Effect of Exchange Rate Changes on Cash | (10 |
) |
(53 |
) |
||||
| Net Change in Cash | $ | (806 |
) |
$ | 256 |
|
||
| Cash - Beginning of Year | 2,481 |
|
2,225 |
|
||||
| Cash - End of Year | $ | 1,675 |
|
$ | 2,481 |
|
||
| THREE MONTHS ENDED | TWELVE MONTHS ENDED | ||||||||||||||
| December 31, | December 31, | ||||||||||||||
| RECONCILIATION OF NET INCOME (LOSS) TO EBITDA | 2023 |
2022 |
2023 |
2022 |
|||||||||||
| ($ in thousands ) | |||||||||||||||
| Net Income (Loss) | $ | 4,352 |
|
$ | (381 |
) |
6,874 |
|
$ | 2,010 |
|||||
| Interest Expense | 122 |
|
74 |
|
487 |
|
411 |
||||||||
| Income Tax (Benefit) Expense | (1,797 |
) |
1,056 |
|
(1,408 |
) |
1,467 |
||||||||
| Depreciation and Amortization Expense | 511 |
|
478 |
|
2,050 |
|
1,918 |
||||||||
| EBITDA | $ | 3,188 |
|
$ | 1,227 |
|
8,003 |
|
$ | 5,791 |
|||||
